Meadow Creek Investment Management’s BELLUS Health Inc. BLU Stock Holding History

Meadow Creek Investment Management’s Portfolio BLU Stock Details BLU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$48K	Buy	+7,548	New	+$53.3K	﹤0.01%	1268

Other funds holding BLU

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

Meadow Creek Investment Management's BLU Position: Q3 2019 in Review

Meadow Creek Investment Management opened a new position in BELLUS Health Inc. (BLU) in Q3 2019: 7,548 shares worth $48K. The stake represents ﹤0.01% of the portfolio and ranks #1268 among its holdings.

40 funds tracked by Wall St. Rank hold BLU as of Q3 2019.

Meadow Creek Investment Management held 7,548 shares of BELLUS Health Inc. worth $48K as of Q3 2019.
BELLUS Health Inc. was a new Meadow Creek Investment Management position in Q3 2019.
BELLUS Health Inc. made up ﹤0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #1268 holding.
40 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.